Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 24 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Boutari, Chrysoula  [Clear All Filters]
Journal Article
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2021).  Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward.. Metabolism. 122, 154781.
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Doumas, M., Stavropoulos K. V., Boutari C., Imprialos K. P., & Karagiannis A. (2017).  Blood pressure and cardiovascular outcomes: a closer look.. Lancet. 389(10076), 1295-1296.
Stavropoulos, K., Imprialos K. P., Boutari C., Athyros V. G., & Karagiannis A. I. (2016).  Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?. J Clin Hypertens (Greenwich). 18(10), 1073.
Doumas, M., Boutari C., Tsioufis C., Dimitriadis K., Triantafyllou A., & Douma S. (2017).  Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension.. Curr Vasc Pharmacol. 16(1), 10-14.
Polyzos, S. A., Kang E. Seok, Boutari C., Rhee E-J., & Mantzoros C. S. (2020).  Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.. Metabolism. 154203.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., Athyros V. G., & Karagiannis A. I. (2016).  Current challenges in antihypertensive treatment in the elderly.. Pol Arch Med Wewn. 126(7-8), 540-51.
Imprialos, K., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2016).  Depression in hypertensive patients: the role of comorbidities.. J Hypertens. 34(7), 1441.
Imprialos, K., Boutari C., & Doumas M. (2016).  Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function.. JAMA Intern Med. 176(3), 409.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Pavlidis A., Papadopoulou M., et al. (2013).  Effect of prior treatment with different statins on stroke severity and functional outcome at discharge in patients with acute ischemic stroke.. Int J Stroke. 8(7), E49.
Boutari, C., Pappas P. D., Mintziori G., Nigdelis M. P., Athanasiadis L., Goulis D. G., et al. (2020).  The effect of underweight on female and male reproduction.. Metabolism. 107, 154229.
Papadopoulou, E., Varouktsi A., Lazaridis A., Boutari C., & Doumas M. (2015).  Erectile dysfunction in chronic kidney disease: From pathophysiology to management.. World J Nephrol. 4(3), 379-87.
Faselis, C., Boutari C., Doumas M., Imprialos K., Stavropoulos K., & Kokkinos P. (2017).  Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun.. Curr Pharm Des. 23(10), 1540-1550.
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2019).  Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?. Metabolism. 96, vi-xi.
Boutari, C., Stavropoulos K., Imprialos K., Doumas M., & Karagiannis A. (2016).  PATHWAY-2: spironolactone for resistant hypertension.. Lancet. 387(10026), 1371-1372.
Tziomalos, K., Giampatzis V., Bouziana S., Pavlidis A., Spanou M., Papadopoulou M., et al. (2014).  Predictive value of the ankle brachial index in patients with acute ischemic stroke.. Vasa. 43(1), 55-61.
Imprialos, K. P., Boutari C., Stavropoulos K., Sampani E., & Karagiannis A. I. (2016).  Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?. J Clin Hypertens (Greenwich). 18(8), 828.
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2019).  Renovascular Hypertension: Novel Insights:. Current Hypertension Reviews. 15,
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2020).  Renovascular Hypertension: Novel Insights.. Curr Hypertens Rev. 16(1), 24-29.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2017).  Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?. J Neurol Neurosurg Psychiatry. 88(3), 249-253.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές